Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111896139 | 11189613 | 9 | F | 20070904 | 20160923 | 20150615 | 20160930 | EXP | US-DSJP-DSU-2015-101335 | DAIICHI | 0.00 | Y | 0.00000 | 20160930 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111896139 | 11189613 | 1 | PS | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 40 MG, QD | Y | 21286 | 40 | MG | TABLET | QD | |||||
| 111896139 | 11189613 | 2 | SS | BENICAR HCT | HYDROCHLOROTHIAZIDEOLMESARTAN MEDOXOMIL | 1 | 40MG/25 MG, UNK | Y | 0 | 1 | DF | FILM-COATED TABLET | |||||||
| 111896139 | 11189613 | 3 | C | PAXIL | PAROXETINE HYDROCHLORIDE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | TABLET | QD | ||||||
| 111896139 | 11189613 | 4 | C | FOSAMAX | ALENDRONATE SODIUM | 1 | Oral | 70 MG, ONCE EVERY 1 WK | 0 | 70 | MG | TABLET | /wk | ||||||
| 111896139 | 11189613 | 5 | C | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | Oral | 500 MG, QD | 0 | 500 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 111896139 | 11189613 | 1 | Product used for unknown indication |
| 111896139 | 11189613 | 2 | Hypertension |
| 111896139 | 11189613 | 3 | Product used for unknown indication |
| 111896139 | 11189613 | 4 | Osteoporosis |
| 111896139 | 11189613 | 5 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 111896139 | 11189613 | OT |
| 111896139 | 11189613 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 111896139 | 11189613 | Acute kidney injury | |
| 111896139 | 11189613 | Ankle fracture | |
| 111896139 | 11189613 | Bone density decreased | |
| 111896139 | 11189613 | Coeliac disease | |
| 111896139 | 11189613 | Deep vein thrombosis | |
| 111896139 | 11189613 | Hiatus hernia | |
| 111896139 | 11189613 | Hip fracture | |
| 111896139 | 11189613 | Hypotension | |
| 111896139 | 11189613 | Inflammatory bowel disease | |
| 111896139 | 11189613 | Malabsorption | |
| 111896139 | 11189613 | Oesophagitis | |
| 111896139 | 11189613 | Reactive gastropathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 111896139 | 11189613 | 2 | 200605 | 20090515 | 0 | |
| 111896139 | 11189613 | 3 | 200110 | 0 |